Literature DB >> 23954692

Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury.

Federico Salomone1, Ignazio Barbagallo, Lidia Puzzo, Cateno Piazza, Giovanni Li Volti.   

Abstract

OBJECTIVE: Acetaminophen intoxication is a leading cause of acute liver failure. Liver transplantation for acute liver failure is limited by the availability of donor organs. In this study, we aimed at identifying if the transplantation of adipose tissue-mesenchymal stem cells (ASCs) may exert therapeutic effects on acetaminophen-induced liver injury.
METHODS: ASCs were isolated from human subcutaneous tissue and were transfected with a green fluorescent protein (GFP). Sprague-Dawley rats were administrated 300mg/kg of acetaminophen intraperitoneally and were transplanted with ASCs or vehicle. After 24h from acetaminophen administration, rats were sacrificed. Hepatic levels of isoprostanes, 8-hydroxyguanosine (8-OHG), nitrites/nitrates and reduced glutathione (GSH) were determined as markers of oxidative stress; JNK phosphorylation and hepatic levels of inflammatory cytokines and regeneration factors were also assessed.
RESULTS: Transplantation of ASCs decreased AST, ALT and prothrombin time to the levels observed in control rats. Transplanted animals had normal plasma ammonia and did not display clinical encephalopathy. Liver sections of intoxicated rats treated with vehicle showed lobular necrosis and diffuse vacuolar degeneration; in rats transplanted with ASCs liver injury was almost absent. Transplantation of ASCs decreased liver isoprostanes, 8-OHG and nitrite-nitrates to the levels of control rats, while preserving GSH. Consistently, hepatic levels of TNF-α, MCP-1, IL-1β, ICAM-1 and phospho-JNK were markedly increased in rats treated with vehicle and were restored to the levels of controls in animals transplanted with ASCs. Furthermore, ASC transplantation increased liver expression of cyclin D1 and PCNA, two established hepatocyte regeneration factors, whereas ASCs were not able to metabolize acetaminophen in vitro.
CONCLUSION: In this study, we demonstrated that ASC transplantation is effective in treating acetaminophen liver injury by enhancing hepatocyte regeneration and inhibiting liver stress and inflammatory signaling.
© 2013.

Entities:  

Keywords:  8-OHG; 8-hydroxyguanosine; ALF; ASCs; BM-MSCs; GFP; GSH; MSCs; OLT; PCNA; acute liver failure; adipose tissue mesenchymal stem cells; bone marrow mesenchymal stem cells; green fluorescent protein; mesenchymal stem cells; orthotopic liver transplantation; proliferating cell nuclear antigen; reduced glutathione

Mesh:

Substances:

Year:  2013        PMID: 23954692     DOI: 10.1016/j.scr.2013.07.003

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  39 in total

1.  Protective properties of the cultured stem cell proteome studied in an animal model of acetaminophen-induced acute liver failure.

Authors:  Andrey Alexandrovich Temnov; Konstantin Arkadevich Rogov; Alla Nikolaevna Sklifas; Elena Valerievna Klychnikova; Markus Hartl; Kristina Djinovic-Carugo; Alexej Charnagalov
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

2.  Amelioration of aflatoxin acute hepatitis rat model by bone marrow mesenchymal stem cells and their hepatogenic differentiation.

Authors:  Faten A M Abo-Aziza; Abdel Kader A Zaki; Rana M Adel; Ahmed Fotouh
Journal:  Vet World       Date:  2022-05-27

3.  Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts.

Authors:  David S Umbaugh; Rupal P Soder; Nga T Nguyen; Olamide Adelusi; Dakota R Robarts; Ben Woolbright; Luqi Duan; Sunil Abhyankar; Buddhadeb Dawn; Udayan Apte; Hartmut Jaeschke; Anup Ramachandran
Journal:  Arch Toxicol       Date:  2022-09-04       Impact factor: 6.168

Review 4.  Recent updates on phthalate exposure and human health: a special focus on liver toxicity and stem cell regeneration.

Authors:  Sarva Mangala Praveena; Seoh Wei Teh; Ranjith Kumar Rajendran; Narayanan Kannan; Chu-Ching Lin; Rozaini Abdullah; Suresh Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2018-03-15       Impact factor: 4.223

Review 5.  Stem cell-based regenerative opportunities for the liver: State of the art and beyond.

Authors:  Eleftheria Tsolaki; Evangelia Yannaki
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 6.  Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.

Authors:  Daniele Tibullo; Giovanni Li Volti; Cesarina Giallongo; Sonia Grasso; Daniele Tomassoni; Carmelina Daniela Anfuso; Gabriella Lupo; Francesco Amenta; Roberto Avola; Vincenzo Bramanti
Journal:  Inflamm Res       Date:  2017-07-04       Impact factor: 4.575

Review 7.  Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.

Authors:  Xiang-Rui Ma; Ya-Ling Tang; Ming Xuan; Zheng Chang; Xiao-Yi Wang; Xin-Hua Liang
Journal:  Gastroenterol Res Pract       Date:  2015-03-15       Impact factor: 2.260

8.  Autoserum: An Optimal Supplement for Bone Marrow Mesenchymal Stem Cells of Liver-Injured Rats.

Authors:  Qinglin Zhang; Xun Sun; Jianxun Ding; Ping He; Yujia Liu; Hongjing Cheng; Changlin Zhou; Xiangwei Meng
Journal:  Stem Cells Int       Date:  2015-05-24       Impact factor: 5.443

9.  Human bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury.

Authors:  Peggy Stock; Sandra Brückner; Sandra Winkler; Matthias M Dollinger; Bruno Christ
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923

Review 10.  Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?

Authors:  Andrew Owen; Philip N Newsome
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-27       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.